The financial regulator in the US has sent letters ... of more than 100 patents held by manufacturers of brand-name asthma inhalers, epinephrine autoinjectors, and other drug products, and has ...

A major obstacle to faster US market entry is the delay caused by protracted patent litigation. Drug manufacturers often ... 3 This landmark case established that biosimilar companies are not ...

Since then, it has grown into one of Astellas’ top-selling drugs ... up nearly 10%. The case – heard in a Delaware district court – was focused on US Patent No. 10,842,780 covering extended ...

The patent application No. 17/309,952 entitled “An A3 adenosine receptor ligand for use for achieving a fat loss effect”, has been accepted by the US Patent Office, will be issued on February ...

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

However, P V Appaji, former director general of Pharmexcil finds that the interest of Indian companies to get approvals for ...

Bifunctional Compositions for the Treatment of Cancer .1 This drug, which is often used to treat malaria, is being repurposed by Armaceutica, Inc. to treat various types of cancer.

After a run of court victories in a five-year patent dispute with the U.S. government ... disclosed in the case, which involved the government’s patents on Gilead’s HIV drugs Truvada and ...

The Namodenoson oral drug is well positioned in the field of anti-obesity agents due to its activity and favorable safety profile Ramat Gan, Israel, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Can-Fite ...

The case was brought because visa applicants must by law declare whether they have taken drugs. Failure to do so can lead to deportation, and Heritage wanted the US Government to release the ...